skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Chlordecone impairs Na(+)-stimulated L-( sup 3 H)glutamate transport and mobility of 16-doxyl stearate in rat liver plasma membrane vesicles

Journal Article · · Toxicology and Applied Pharmacology; (USA)

Chlordecone (CD) treatment of rat liver plasma membranes (LPM) provided in vitro evidence for mechanisms of in vivo liver dysfunction caused by CD. LPM preparations enriched 14- to 19-fold in the bile canalicular markers gamma-glutamyl transpeptidase, alkaline phosphatase, and leucine aminopeptidase were isolated from male Sprague-Dawley rats. CD inhibited the bile canalicular-specific active transport of Na(+)-stimulated L-({sup 3}H)glutamate in LPM vesicles. CD (0.08 and 0.5 mumol/mg protein) reduced both the initial velocity and the maximum level of Na(+)-stimulated L-(3H)glutamate uptake without significantly reducing Na(+)-independent uptake. In vitro treatment of LPM with CD (0.2-1.0 mumols/mg protein) also reduced the mobility of a 16-doxyl stearate spin label probe in a concentration-dependent manner. No change in mobility was apparent at CD concentrations below 0.2 mumol/mg protein. These results demonstrated that CD impaired a bile canalicular-specific transport system and induced liver plasma membrane perturbation. Na(+)-stimulated L-({sup 3}H)glutamate uptake was more sensitive to CD than was detectable immobilization of the spin label probe.

OSTI ID:
6172762
Journal Information:
Toxicology and Applied Pharmacology; (USA), Vol. 105:2; ISSN 0041-008X
Country of Publication:
United States
Language:
English